These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 8990063

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis.
    Teive HA, Troiano AR, Germiniani FM, Werneck LC.
    Parkinsonism Relat Disord; 2004 Jun; 10(4):243-5. PubMed ID: 15120099
    [Abstract] [Full Text] [Related]

  • 4. Cinnarizine-induced parkinsonism: ten years later.
    Martí-Massó JF, Poza JJ.
    Mov Disord; 1998 May; 13(3):453-6. PubMed ID: 9613736
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Permanent non-progressive cinnarizine and flunarizine-induced parkinsonism: An under-recognized tardive syndrome in the elderly?
    Calzetti S, Negrotti A.
    J Neurol Sci; 2023 Jan 15; 444():120526. PubMed ID: 36584558
    [Abstract] [Full Text] [Related]

  • 7. Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine.
    Capellà D, Laporte JR, Castel JM, Tristán C, Cos A, Morales-Olivas FJ.
    BMJ; 1988 Sep 17; 297(6650):722-3. PubMed ID: 3147743
    [No Abstract] [Full Text] [Related]

  • 8. Iatrogenic parkinsonism: the role of flunarizine and cinnarizine.
    Miguel R, Correia AS, Bugalho P.
    J Parkinsons Dis; 2014 Sep 17; 4(4):645-9. PubMed ID: 25125483
    [Abstract] [Full Text] [Related]

  • 9. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
    Llau ME, Nguyen L, Senard JM, Rascol O, Montastruc JL.
    Rev Neurol (Paris); 1994 Nov 17; 150(11):757-62. PubMed ID: 7597368
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Extrapyramidal symptoms after exposure to calcium channel blocker-flunarizine or cinnarizine.
    Jhang KM, Huang JY, Nfor ON, Tung YC, Ku WY, Lee CT, Liaw YP.
    Eur J Clin Pharmacol; 2017 Jul 17; 73(7):911-916. PubMed ID: 28386684
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [New forms of Parkinsonism in hospice care].
    Baquero M, Domínguez-Sanz FJ, Burguera JA, Cruz Campos GA, Muñoz R.
    Rev Neurol; 1995 Jul 17; 23(123):964-8. PubMed ID: 8556606
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Parkinsonism, depression and akathisia induced by flunarizine, a calcium entry blockade--report of 31 cases].
    Kuzuhara S, Kohara N, Ohkawa Y, Fuse S, Yamanouchi H.
    Rinsho Shinkeigaku; 1989 Jun 17; 29(6):681-6. PubMed ID: 2582681
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Drug-induced or aggravated parkinsonism: clinical signs and the changing pattern of implicated drugs].
    Martí Massó JF, Poza JJ.
    Neurologia; 1996 Jan 17; 11(1):10-5. PubMed ID: 8714170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.